Status:
RECRUITING
Bilateral Essential Tremor Treatment With Gamma Knife
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
University Health Network, Toronto
Conditions:
Essential Tremor
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Combined Phase II/III, multi-center, prospective, single-blinded trial. Ten (10) patients with essential tremor who previously underwent successful and uncomplicated GK thalamotomy for essential trem...
Eligibility Criteria
Inclusion
- Patients must be ≥ 18 years
- The patient has a primary diagnosis of ET or ET plus confirmed by a movement disorder neurologist;
- The patient previously underwent a GK thalamotomy (\> 12 months ago);
- The tremor on the untreated side negatively impacts the patients' quality of life;
- The patient wants treatment of the contralateral side.
Exclusion
- Clinically relevant gait and/or balance impairment (e.g. wide-based, more than 2 falls/months, wheelchair, walker, cane use);
- Clinically relevant speech impairment (e.g. impairment of intelligibility);
- Inability to comply with the follow-up schedule;
- Refusal of the treating physician.
Key Trial Info
Start Date :
June 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04748640
Start Date
June 8 2021
End Date
October 1 2026
Last Update
November 17 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital, University Health Network
Toronto, Ontario, Canada, M5T 2S8
2
CIUSSS de l'Estrie-CHUS - Hôpital Fleurimont
Sherbrooke, Quebec, Canada